表紙
市場調査レポート

筋痙縮:世界の治験レビュー

Muscle Spasticity Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 308782
出版日 ページ情報 英文 116 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
筋痙縮:世界の治験レビュー Muscle Spasticity Global Clinical Trials Review, H2, 2014
出版日: 2014年07月21日 ページ情報: 英文 116 Pages
概要

当レポートでは、筋痙縮に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

イントロダクション

  • 筋痙縮
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する筋痙縮の治験件数比率

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:中枢神経系の治験件数に対する筋痙縮の治験件数比率

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

筋痙縮治療薬の治験に携わっている主要企業

有望な薬剤

治験のプロファイル

  • 主要企業の治験の概要
    • Allergan, Inc.
    • Ipsen S.A.
    • Merz Pharma GmbH & Co. KgaA
    • Torrent Power Limited
    • Sun Pharma Advanced Research Company
    • MediciNova, Inc.
    • Acorda Therapeutics, Inc.
    • GlaxoSmithKline plc
    • Daewoong Co., Ltd.
    • ASIS Corporation
  • 代表的な研究機関・病院の治験の概要
    • National Institute of Neurological Disorders and Stroke
    • University of Alberta
    • Georgetown University
    • Medical University of Vienna
    • Institut fur Klinisch-Kardiovaskulare Forschung GmbH
    • University of Manitoba
    • Assistance Publique Hopitaux De Marseille
    • Eunice Kennedy Shriver National Institute of Child Health and Human Development
    • Vanderbilt University
    • U.S. Department of Veterans Affairs

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2250CTIDB

GlobalData's clinical trial report, "Muscle Spasticity Global Clinical Trials Review, H2, 2014" provides data on the Muscle Spasticity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Spasticity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Muscle Spasticity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Muscle Spasticity
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Muscle Spasticity to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Muscle Spasticity to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Muscle Spasticity
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Muscle Spasticity Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Ipsen S.A.
      • Clinical Trial Overview of Ipsen S.A.
      • Merz Pharma GmbH & Co. KgaA
      • Clinical Trial Overview of Merz Pharma GmbH & Co. KgaA
      • Torrent Power Limited
      • Clinical Trial Overview of Torrent Power Limited
      • Sun Pharma Advanced Research Company
      • Clinical Trial Overview of Sun Pharma Advanced Research Company
      • MediciNova, Inc.
      • Clinical Trial Overview of MediciNova, Inc.
      • Acorda Therapeutics, Inc.
      • Clinical Trial Overview of Acorda Therapeutics, Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Daewoong Co., Ltd.
      • Clinical Trial Overview of Daewoong Co., Ltd.
      • ASIS Corporation
      • Clinical Trial Overview of ASIS Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • University of Alberta
      • Clinical Trial Overview of University of Alberta
      • Georgetown University
      • Clinical Trial Overview of Georgetown University
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Institut fur Klinisch-Kardiovaskulare Forschung GmbH
      • Clinical Trial Overview of Institut fur Klinisch-Kardiovaskulare Forschung GmbH
      • University of Manitoba
      • Clinical Trial Overview of University of Manitoba
      • Assistance Publique Hopitaux De Marseille
      • Clinical Trial Overview of Assistance Publique Hopitaux De Marseille
      • Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Muscle Spasticity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Muscle Spasticity Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Ipsen S.A., 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz Pharma GmbH & Co. KgaA, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Power Limited, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharma Advanced Research Company, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Daewoong Co., Ltd., 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by ASIS Corporation, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alberta, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut fur Klinisch-Kardiovaskulare Forschung GmbH, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique Hopitaux De Marseille, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*

List of Figures

  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Muscle Spasticity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Muscle Spasticity to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Muscle Spasticity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Muscle Spasticity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Muscle Spasticity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Muscle Spasticity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top